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The mode of action of PTHrP in the regulation of sea bream 
(Sparus auratus) interrenal cortisol production was studied 
in vitro using a dynamic superfusion system. Piscine (1– 
34)PTHrP (10—6–10—11 M) stimulated cortisol production in a 
dose-dependent manner. The ED50 of (1–34)PTHrP was 2.8 
times higher than that of (1–39)ACTH, and maximum increase 
in cortisol production in response to 10—8 M of (1–34)PTHrP 
was approximately 7-fold lower than for 10—8 M of (1–39)ACTH. 
In contrast to (1–34)PTHrP, piscine (10 –20)PTHrP, (79 – 
93)PTHrP, and (100 –125)PTHrP (10—9–10—7 M) did not stimu- 
late cortisol production. The effect of piscine (1–34)PTHrP on 
cortisol production was abolished by N-terminal peptides in 
which the first amino acid (Ser) was absent and by simulta- 
neous addition of inhibitors of the adenylyl cyclase-protein 
kinase A and phospholipase C-protein kinase C intracellular 
 
 
THrP IS A protein that shares sequence similarity to the 
N terminus of PTH, a product of the parathyroid gland 
and a key hormone in calcium metabolism in mammals. 
PTHrP is a paracrine factor that is produced in a range of 
different tissues and has a wide spectrum of biological ac- 
tivity. Posttranslational processing of PTHrP, which contains 
multibasic endoproteolytic sites (multi-K/R), has been 
shown to give rise to amino-terminal, mid-region, and 
carboxy-terminal mature secretory forms of PTHrP (1). The 
processing pathways and activities of the various peptides 
arising from PTHrP are still not fully characterized in mam- 
mals and remain the subject of considerable study. 
PTHrP has been identified in most vertebrate groups, in- 
cluding teleost fish in which a PTHrP-like protein was iden- 
tified in tissue and plasma, and subsequently, the cDNA and 
gene were isolated from sea bream (Sparus auratus) and the 
puffer fish (Fugu rubripes), respectively (2, 3). Moreover, a 
PTH-like factor has also recently been identified in fish (4), 
which shares 59% identity with PTHrP isolated from puffer 
fish, sea bream, and flounder (Platichthys flesus). Multiple 
sequence alignment of the amino acid sequence of PTHrP 
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pathways but not by each separately. The PTHrP-induced 
signal transduction was further investigated by measure- 
ments of cAMP production and [H3]myo-inositol incorpora- 
tion in an interrenal cell suspension. Piscine (1–34)PTHrP 
increased cAMP and total inositol phosphate accumulation, 
which is indicative that the mechanism of action of PTHrP in 
interrenal tissue involves the activation of both the adenylyl 
cyclase-cAMP and phospholipase C-inositol phosphate signal- 
ing pathways. These results, together with the expression of 
mRNA for PTHrP and  for  PTH  receptor  (PTHR)  type  1  
and PTHR type 3 receptors in sea bream interrenal tissue, 
suggest a specific paracrine or autocrine steroidogenic action 
of PTHrP mediated by the PTHRs. (Endocrinology 146: 71–76, 
2005) 
 
 
 
from fish and mammals indicates that they share 52% iden- 
tity in the N-terminal region [(1–34)PTHrP] (2), raising the 
question of whether there is conservation of function. 
PTHrP brings about its biological activity by binding to 
the G protein-coupled, PTH receptor (PTHR), and stimu- 
lates the adenylyl cyclase (AC)-cAMP and phospholipase  
C (PLC)-inositol phosphate (IP) signaling pathways (5). Of 
both the PTHRs cloned in human, only PTHR type 1 
(PTH1R) responds to PTHrP and strongly activates the 
AC-protein  kinase  A  (PKA)  signaling  pathway  and,  to a 
lesser extent, the PLC-protein kinase C (PKC)-intracellular 
Ca2+ signaling pathway (6). Recently, three different 
teleost PTHRs [(PTH1R, PTHR type 2 (PTH2R), and PTHR 
type 3(PTH3R)] were identified in zebrafish (Danio rerio), 
and receptor activation was characterized in vitro (7, 8). 
However, PTHRs have still not been isolated from any 
other teleost, and the tissue distribution and binding char- 
acteristics of the native receptors to fish PTHrP remains to 
be characterized. 
In mammals, PTHrP has recently been reported in various 
tissues of the hypothalamus-pituitary-adrenal axis (9). The 
interaction between hypothalamic CRH and pituitary ACTH 
regulates cortisol production (10). Although a range of other 
hormones and peptides also modulate this process, PTHrP 
was recently shown to stimulate cortisol release from dis- 
persed human adrenocortical cells (11). Moreover, in mam- 
mals, glucocorticoids regulate the expression of the gene 
encoding PTHrP (12). The teleost fish interrenal gland is 
homologous to the mammalian adrenal gland, and in both, 
the basic structure is made up of cords. However, whereas 
      
 
in mammals, a central medulla of chromaffin tissue is sur- 
rounded by a zoned adrenal cortex, in fish, adrenocortical 
cells are intermingled with chromaffin cells (13). The pe- 
ripheral zona glomerulosa of the adrenal gland produces 
aldosterone, whereas a zona fasciculate produces glucocor- 
ticoids, including cortisol. Aldosterone is not commonly de- 
tected in teleost fish (13). The presence of PTHrP in the brain, 
pituitary gland, and interrenal tissue of the sea bream (2, 14) 
raises questions about its potential involvement in control of 
cortisol production in fish. In the present study, the capacity 
of N-terminal peptides of piscine PTHrP to stimulate cortisol 
release from sea bream interrenal tissue is established. To 
characterize the corticotropic activity of PTHrP and the 
amino acid residues important for receptor activation in this 
tissue, several N-terminal truncated forms of piscine PTHrP 
are used. The PTHR types present in piscine interrenal tissue 
and the intracellular signaling mechanisms activated after 
PTHR binding are established. 
 
Materials and Methods 
Chemicals 
Piscine (1–34)PTHrP, (2–34)PTHrP, (3–34)PTHrP, (7–34)PTHrP, (10 – 
20)PTHrP, (79 –93)PTHrP, and (100 –125)PTHrP were synthesized  
by Genemed Synthesis, Inc (San Francisco, CA). Human (1–39)ACTH, 
corticotropin-inhibiting peptide (CIP), phosphodiesterase inhibitor (3- 
isobutyl-1-methylxanthine, IMBX), PLC inhibitor (U-73122), BSA, MEM, 
collagenase/dispase 2-phenoxyethanol, and other laboratory reagents 
were purchased from Sigma-Aldrich (Madrid, Spain). SQ-22536, an AC 
inhibitor, was obtained from Calbiochem (La Jolla, CA). The RIA kit for 
cAMP and [H3]myo-inositol (specific activity, 629 GBq/mmol) were 
purchased from Amersham Biosciences (Little Chalfont, UK), and an 
in-house assay was used to measure cortisol. 
 
Fish 
Sexually immature gilthead sea bream (S. auratus), weighing 80 –120 
g, were maintained at the Ramalhete experimental station of the Uni- 
versity of Algarve (Faro, Portugal) under constant environmental con- 
ditions; the photoperiod was 14 h of daylight and 10 h of dark, and the 
water temperature was 22 ± 1 C. Fish were kept in 5 m3 seawater tanks 
in an open circuit, which received a continuous flow (250 cm3·h—1) of 
well-aerated seawater. Tanks were stocked at a density of 4 kg·m—3, and 
fish were fed twice daily at 0900 h and 1800 h with 1% body weight 
commercial dry pellets (PROVIMI, Lisbon, Portugal). Food was with- 
held from fish for 24 h before sampling. 
 
In vitro superfusion 
All fish belonging to the same sampling group were rapidly captured 
and anesthetized with an overdose of 2-phenoxyethanol (1:1000 vol/ 
vol). Intact head kidney was quickly dissected from each fish placed in 
superfusion chambers and superfused with buffered HEPES Ringer 
solution (HEPES, 15 mm; pH 7.38) containing NaCl (171 mm), KCl (2 
mm), CaCl2/2H2O (2 mm), 0.25% (wt/vol) glucose, and 0.03% BSA 
(wt/vol). This medium was pumped through the superfusion chambers 
at a rate of 75 µl·min—1 by means of a multichannel peristaltic pump 
(Masterflex; Cole-Palmer, Vernon Hills, IL) and fractions of 1.5 ml were 
collected in ice. The whole system was maintained at a constant tem- 
perature of 18 C. Previous studies with this system indicated that cortisol 
reaches stable basal levels after3h of superfusion (14). Therefore, when 
a steady basal state was reached, tissue was stimulated for 20 min with 
the different treatments applied. To characterize the dose-response 
curves of cortisol production for different regions of the PTHrP mole- 
cule, the head kidney was perfused with the following peptides: Fugu 
and flounder (1–34)PTHrP from 10—6–10—12 m; sea bream (10 –20)PTHrP 
from 10—7–10—9 m; sea bream (79 –93)PTHrP from 10—7–10—9 m; and sea 
bream (100 –125)PTHrP from 10—7–10—9 m. The overall cortisol synthetic 
capacity of the head kidney was determined by perfusing 10—8 m human 
(1–39)ACTH. The effect of N-terminal truncated forms of sea bream 
PTHrP on cortisol production by the head kidney was determined by 
comparing the production rates when perfusing with 10—8 m Fugu (1– 
34)PTHrP, 10—8 m Fugu (2–34)PTHrP, 10—8 m Fugu (3–34)PTHrP, and 
10—8 m Fugu (7–34)PTHrP. To establish whether the cortisol stimulatory 
activity of PTHrP was occurring through its binding to the ACTH 
receptor or through binding to a PTHR, 10—8 m Fugu (1–34)PTHrP was 
perfused alone or in the presence of 10—6 m of CIP, Fugu (2–34)PTHrP, 
Fugu (3–34)PTHrP, and Fugu (7–34)PTHrP. In a final group of experi- 
ments aimed at establishing the principal signaling pathway used by 
PTHrP in the head kidney, Fugu (1–34)PTHrP (10—8 m) was used to 
perfuse a head kidney preparation alone or in the presence of a PLC 
inhibitor (10—4 m SQ-22536) and/or an AC inhibitor (10—5 m U-73122). 
The cortisol released in the head kidney fractions was determined by 
RIA and expressed as nanogram of cortisol per gram of head kidney per 
hour or as percentage of basal release, considering as 100% basal the 
release in the 30 min preceding the application of a stimulus. 
 
Interrenal cell suspension 
The preparation of an interrenal cell suspension for the measurements 
of cAMP and [H3]myo-inositol incorporation was carried out as previ- 
ously described (15). In brief, the head kidney of individual fish was 
removed and placed in a culture dish containing complete medium 
(MEM supplemented with 5 g·liter—1 BSA; 2.2 g·liter—1 NaHCO3; 2 
g·liter—1 NaCl, pH 7.4; 348 mosmol). The tissue was washed with com- 
plete medium, resuspended in fresh complete medium containing 2 
mg·ml—1 collagenase/dispase, and incubated for 15 min with gentle 
agitation. The solution was then filtered with a 60-µm mesh cloth, and 
the filtrate was centrifuged at 1500 rpm for 5 min. The pellet was 
resuspended in complete medium, and the cells were counted using a 
hemocytometer. Cell viability estimated by tryptan blue at the end of the 
isolation procedure was 92 ± 4.6%. 
 
Measurement of cAMP production 
To measure cAMP, isolated interrenal cells were plated into 24-well 
sterile culture plates (Costar, Corning Incorporated, Corning, NY) at 2 × 
106 cells·well—1 in 1 ml complete medium. After 30 min of 
preincubation in complete medium containing 1 mm IMBX, cells were 
incubated for an additional 30-min period in complete medium-IMBX 
in the presence or absence of 10—8 m Fugu (1–34)PTHrP or 10—8 m Fugu 
(7–34)PTHrP. Culture plates were then centrifuged, the medium was 
aspirated, and cells were resuspended in 0.01 m PBS with 4 mm EDTA. 
Subsequently, the cells were sonicated, and aliquots were taken for 
protein determi- nation. Thereafter, samples were boiled and 
centrifuged at 5000 rpm for 5 min at 4 C. The supernatant was 
removed and stored at —20 C. cAMP concentration was determined by 
RIA using a kit (TRK 432; Amersham Biotrak). Results are reported as 
picomoles of cAMP per milligram of total protein. Total protein was 
determined by the Lowry method (16). 
 
Measurement of [H3]myo-inositol incorporation 
[H3]myo-inositol incorporation was determined following the 
method described by Ramirez et al. (17) with small modifications. In- 
terrenal cells were plated in 24-well plates at 2 × 106 cells·well—1 in1 
ml complete medium. After 1 h of preincubation, cells were incubated 
for 30 min in complete medium containing [H3]myo-inositol (37 
MBq·ml—1; specific activity, 629 MBq·nmol—1) in the presence or 
absence of 10—8 m of Fugu (1–34)PTHrP or 10—8 m Fugu (7–34)PTHrP. 
The reaction was stopped by centrifugation at 2500 rpm at 4 C and by 
suspending the pellet in 500 µl ice-cold 10% trichloroacetic acid. The 
contents were transferred from 24-well culture plates into 1.5-ml 
microtubes and son- icated. An aliquot was taken for total protein 
determination, and the remainder was centrifuged at 12,000 rpm for 15 
min at 4 C. The super- natant, containing IPs, was removed and 
measured in a scintillation counter (LS6100; Beckman Coulter, 
Fullerton, CA). Chloroform-meth- anol (2:1, vol/vol) was then added to 
the pellet to extract the phospho- inositide phosphates (PIPs). After 
centrifugation at 12,000 rpm for 15 min at 4 C, this supernatant was also 
removed and counted. Counts obtained for IPs and PIPs were pooled, 
and the results reported corresponded to the total amount of [H3]myo-
inositol incorporated in each sample (phos- 
   
 
phoinositides plus PIPs) and are expressed as counts per minute per 
milligram protein. 
 
RT-PCR of PTHrP and PTHRs 
Sea bream head kidneys were collected and immediately frozen in 
liquid nitrogen. Total RNA was extracted with TRI reagent (Sigma- 
Aldrich, St. Louis, MO), and the final concentration was measured using 
a spectrophotometer (GeneQuant; Amersham Biosciences, Lisbon, Por- 
tugal). The quality of extracted total RNA was determined by agarose 
gel (1.5%) electrophoresis. cDNA synthesis was carried out by adding 
the following to each reaction tube: 1.25 µl oligo dT (1 µg·µl—1; Amer- 
sham Biosciences); 2 µl of 5× RT buffer (Life Technologies, Inc.-BRL, 
Barcelona, Spain); 0.25 µl of MMLV Reverse transcriptase (200 U·µl—
1; Life Technologies, Inc.-BRL); 0.5 µl deoxynucleotide triphosphate 
(10 mm; Amersham Biosciences), and 1 µl dithiothreitol (0.1 m). The 
reaction was allowed to proceed for 3 h at 37 C and was then stopped 
by heating at 65 C for 5 min and stored at —20 C until use. For the RT-
PCRs, 1 µl of cDNA was added to a reaction mixture (50 µl) containing 
10 mm Tris-HCl (pH 9.0), 50 mm KCl, 0.1% Triton X-100, 2 mm MgCl2, 
0.2 mm deoxynucleotide triphosphate, 1.25 U Taq DNA polymerase 
(Promega, Madison, WI), and 10 pmol each of forward and reverse 
primers for the gene of interest. The sea bream PTHrP specific sense 
primer (5'-GAAT- TCAGGAGGTCAGTGAGCCAC-3') and antisense 
primer (5'-AACA- GACCGTGCCCGCCTCCTCTTCTTGTC-3') yielded a 
359-bp product. The sea bream PTH1R specific sense primer (5'-
GCGGCAGTAACA- CATACAGC-3') and antisense primer (5'-
TTTCTCTTTCCTCCTC- CACC-3') yielded a 290-bp product. The sea 
bream PTH3R specific sense primer (5'-
ACATCCACATTCACTTCTTCAC-3') and antisense primer (5'-
GATGAGGGCCACAGGTAGT-3') yielded a 274-bp product. As a 
positive control, plasmids containing cloned PTH1R and PTH3R sub- 
stituted cDNA in the PCR. Elongation factor 1a was used as a control  
to establish the relative quantity of cDNA used in each reaction (18). PCR 
products were visualized by ethidium bromide staining after electro- 
phoresis on 1.5% agarose gels. The bands were excised, purified with 
GFX PCR DNA and Gel Band Purification Kit (Amersham Biosciences), 
cloned into pGem-T-easy plasmid, and used to transform competent 
Escherichia coli. Plasmid DNA was prepared from recombinant E. coli 
using the alkaline lysis method (19) and sequenced (Macrogen Inc., 
Seoul, South Korea). DNA sequence analyses were performed using 
BLAST (20). GenBank accession numbers for sea bream PTHrP, PTH1R, 
and PTH3R are AF197904, AJ619024, and AY547261, respectively. 
 
Biochemical analysis 
Cortisol was determined in head kidney perfusate using a cortisol 
RIA. The cross-reactivity of this antiserum in relation to cortisol was 54% 
for 11-desoxycortisol, 10% for cortisone, 16% for 17,21-dihydroxy-5- 
pregnan-3,11,20-trione, 5% for 11þ,17,21-trihydroxy-5-pregnan-3,20- 
dione, 0.05% for 11-hydroxytestosterone, and less than 0.001% for tes- 
tosterone. Head kidney perfusates (15 µl) were diluted in phosphate 
buffer (300 µl) containing 0.5 g·l—1 gelatin (pH 7.6) and denatured at 70 
C for 30 min. 
 
Data analysis 
Results are presented as mean ± sem of six separate head kidney 
perfusions. Data analysis was carried out using one-way ANOVA fol- 
lowed by the Student-Newman-Keuls test. When nonhomogeneous 
variances were found, the Mann-Whitney and Kruskal-Wallis test were 
applied. The level for accepted statistical significance was P < 0.05. 
Significant differences in the figures are indicated with asterisks (*, P < 
0.05; **, P < 0.01; and ***, P < 0.001). Standard curve analysis was carried 
out with the Pharmacology Module of Sigma Plot, version 8.0 (SPSS Inc., 
Chicago, IL), by fitting of a four-parameter logistic function. 
 
Results 
Of all the piscine PTHrP peptides tested, only the intact 
Fugu and flounder N-terminal fragment (1–34)PTHrP stim- 
ulated, in a dose-dependent fashion, the in vitro release of 
cortisol from isolated sea bream interrenal glands (Fig. 1). 
 
 
FIG. 1. Effect of increasing doses of Fugu (1–34)PTHrP, flounder (1–
37)PTHrP, and sea bream (10 –20)PTHrP, (74 –93)PTHrP, and 
(100 –125)PTHrP on the in vitro release of cortisol from superfused 
sea bream head kidney. Data are given as percentage of basal release 
and represent the mean ± SEM of six independent determinations. 
 
The baseline secretion established for control tissue was 
7.41 nm. The time lag between application of the piscine (1–
34)PTHrP stimulus and the increase in cortisol production by 
the interrenal tissue was similar to that observed when 
ACTH was used to stimulate tissue (both occurred within 20 
min). This is indicative that piscine (1–34)PTHrP has a rapid 
stimulatory action on cortisol production by interrenal tissue 
in fish. Truncated forms of Fugu (1–34)PTHrP, in which the 
first amino acid (2–34), first two amino acids (3–34), or first 
six amino acids (7–34) were removed, failed to stimulate 
cortisol release from head kidney (Fig. 2A). These results 
indicate that amino-terminal deletions of teleost PTHrP af- 
fect the ability of these truncated forms to stimulate in vitro 
cortisol release from interrenal tissue. 
The way in which PTHrP brings about its stimulatory 
action on cortisol production by interrenal tissue was as- 
sessed in a series of experiments with specific inhibitors. 
Piscine (1–34)PTHrP (10—8 m)-stimulated cortisol production 
from interrenal tissue was unaffected by 10—6 m CIP. In 
contrast, CIP effectively blocked 90% of ACTH corticotropic 
activity (data not shown). This suggests that the PTHrP effect 
is not mediated by its binding to an ACTH receptor. How- 
ever, the stimulatory effect of (1–34)PTHrP could be removed 
by co-perfusion with 10—6 m of any of the truncated peptides, 
including (7–34)PTHrP, which is known to act as an antag- 
onist by binding to the PTHR. This is indicative that PTHrP 
binds to a PTHR in the head kidney. Supporting the existence 
of such receptor(s) is the demonstration by RT-PCR that sea 
bream interrenal tissue expresses PTHrP and two PTHRs, 
PTH1R and PTH3R (Fig. 3). Overall, these results strongly 
suggest that PTHrP most likely brings about its effect on 
cortisol production by binding to specific PTHRs. 
To establish which of the receptors and/or signaling path- 
ways is mediating the PTHrP-stimulated cortisol production, 
the effect of AC (10—4 m SQ-22536) and PLC (10—5 m U-73122) 
inhibitors was investigated. When either of the inhibitors 
was added to sea bream interrenal tissue in vitro in the 
   
 
FIG. 3. Amplified products of specific RT-PCR for sea bream PTHrP, 
sea bream PTH1R, and sea bream PTH3R using cDNA prepared from 
sea bream head kidney mRNA. RT-PCR products were fractionated 
on a 1.5% agarose gel and stained with ethidium bromide. EF-1a, 
Elongation factor 1a. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG. 2. A, Effect of ACTH (10—8 M) and intact or truncated forms of 
(1–34)PTHrP (10—8 M) on in vitro cortisol secretion from superfused 
sea bream head kidneys. B, Effect of CIP (10—6 M) and truncated forms 
of (1–34)PTHrP (10—6 M) on (1–34)PTHrP (10—8 M)-stimulated in vitro 
cortisol secretion from superfused sea bream head kidneys. Head 
kidneys were treated with peptides for 20 min. Data represent the 
mean ± SEM of six independent experiments. Asterisks indicate sig- 
nificant difference from control basal release (A) and PTHrP only (B). 
 
presence of piscine (1–34)PTHrP (10—8 m), no significant in- 
hibition of cortisol release was obtained. However, with the 
simultaneous addition of both inhibitors, 10—4 m SQ-22536 
and 10—5 m U-73122, the stimulation of cortisol release from 
sea bream interrenal tissue was totally abolished (Fig. 4). This 
is indicative that both the AC and PLC pathways can be used 
to bring about PTHrP corticosteroidogenic response. cAMP 
release and [H3]myo-inositol incorporation by dispersed in- 
terrenal cells was stimulated 2.5- and 1.8-fold, respectively, 
by piscine (1–34)PTHrP (10—8 m) (Fig. 5). The truncated forms 
of (2–34)PTHrP and (3–34)PTHrP failed to stimulate cAMP 
release and [H3]myo-inositol incorporation (data not shown), 
whereas (7–34)PTHrP significantly increased (P < 0.05) 
[H3]myo-inositol incorporation but not cAMP release (Fig. 5). 
This indicates that the first seven amino acids of the N ter- 
minus of piscine PTHrP are important for optimal AC-cAMP 
signaling pathway activation, but the PTHrP activation of the 
PLC-IP signaling pathway is more complex. 
 
Discussion 
The results from the present study demonstrate that 
PTHrP has corticosteroidogenic activity in fish and the 
ligand determinants of receptor signaling in interrenal 
cells. Piscine (1–34)PTHrP stimulated cortisol release in a 
concentration-dependent manner in interrenal tissue of 
sea bream. The ED50 of (1–34)PTHrP was 2.8 times higher 
than that of (1–39)ACTH (14), and the percent increase of 
cortisol production in response to 10—8 m of (1–34)PTHrP 
was approximately 7-fold lower than for 10—8 m of (1–
39)ACTH. In contrast to (1–34)PTHrP, piscine (10 –20)- 
PTHrP, (79 –93)PTHrP, and (100 –125)PTHrP failed to 
stimulate corticosteroidogenesis at 10—9–10—7 m. The effect 
of piscine (1–34)PTHrP was abolished by N-terminal pep- 
tides in which the first amino acid (Ser) was absent and by 
inhibitors of the AC and PLC  intracellular  pathways. 
These results, together with the expression of mRNA for 
PTHrP and for PTH1R and PTH3R receptors in sea bream 
interrenal tissue, suggest that this is a specific effect me- 
diated by PTHRs, and as observed in mammals (1, 21), this 
is indicative of a paracrine or autocrine effect of PTHrP 
modulating corticosteroid production in this tissue (22). 
 
FIG. 4. Effect of AC inhibitor SQ-22536 (10—4 M) and PLC inhibitor 
U-73122 (10—5 M) on (1–34)PTHrP (10—8 M)-stimulated cortisol se- 
cretion from sea bream head kidneys. Head kidneys were treated with 
peptides and/or inhibitors for 20 min. Data represent the mean ± SEM 
of six independent experiments. Asterisks indicate significant differ- 
ence from (1–34)PTHrP only. 
   
 
 
 
FIG. 5. Effect of (1–34)PTHrP (10—8 M) and (7–34)PTHrP (10—8 M) on 
cAMP production (A) and on incorporation of [H3]myo-inositol (B) by 
dispersed sea bream interrenal cells. Cells were challenged for 30 min 
in the presence of IMBX. Data represent the mean ± SEM of two 
independent determinations in three separate experiments. Asterisks 
indicate significant difference from control. 
 
The possibility that the cortisol stimulatory activity of (1–
34)PTHrP in interrenal tissue was a result of direct inter- 
action with the ACTH receptor was eliminated because CIP, 
at concentrations that effectively abolish ACTH-stimulated 
cortisol release in interrenal tissue, had no effect on (1– 
34)PTHrP-induced cortisol production. This demonstrated 
unequivocally that piscine (1–34)PTHrP stimulates cortisol 
release via another mechanism and is in agreement with a 
glucocorticoid secretagogue effect reported for (1–34)PTHrP 
in human adrenal cells in vitro (5). This indicates that the 
glucocorticoid secretagogue action of the N terminus of 
PTHrP has been conserved during evolution. 
In the present study, amino-terminal deletions in teleost 
PTHrP, such as removal of the first residue (2–34), first two 
residues (3–34), or first six residues (7–34), caused a dramatic 
reduction in the biological potency of (1–34)PTHrP. This 
suggests that, in fish, the first seven amino acids and, in 
particular, the first Ser of the N terminus of piscine PTHrP 
are determinants of the glucocorticoid secretagogue activity. 
A similar observation has been made in humans, in which the 
cortisol stimulatory action of human (1–34)PTHrP was abol- 
ished by the PTHR antagonist (Leu11, d-Trp12)PTHrP (7–34)- 
amide. The importance of an intact N-terminal region of 
PTHrP for biological activity appears to be a general phe- 
nomenon, and amino acid deletions have been observed to 
reduce its potency in cAMP second messenger responses of 
COS-7 cells expressing zebrafish PTHRs (6). 
In mammals, PTH and PTHrP are both expressed in the 
hypothalamus and pituitary gland, whereas PTHRs have 
been found in all components of the hypothalamus-pituitary- 
adrenal axis (9). In common with this observation, PTHrP is 
produced by a variety of endocrine and nonendocrine tissues 
in fish (2, 3, 22, 23). For example, PTHrP and its mRNA have 
been demonstrated in the brain, pituitary, and head kidney 
of sea bream (2, 3, 22). Furthermore, very high to moderate 
concentrations of immunoreactive PTHrP have been de- 
tected, in decreasing order of abundance, in extracts of pi- 
tuitary, head kidney, esophagus, intestine, gill, skin, and 
muscle of the sea bream (22). The high pituitary and circu- 
lating levels of this hormone measured in the sea bream and 
flounder may indicate that in teleosts, in contrast to what is 
observed in mammals, PTHrP, in addition to paracrine and 
autocrine actions, can also act as an endocrine factor (22, 24). 
In mammals, two principal PTHR types have been iden- 
tified, PTH1R and PTH2R (25, 26). Characterization of 
ligand-binding affinity indicates that PTH1R binds equally 
well to human PTHrP and human PTH, whereas PTH2R 
binds preferentially to bovine tuberoinfundibular peptide 
(TIP39) (27). PTH1R is the receptor most frequently charac- 
terized in nonskeletal tissue, which interacts with amino- 
terminal fragments of PTHrP (28, 29). There are relatively 
few studies describing PTHRs in mammalian adrenals. How- 
ever, those studies indicate that in common with other non- 
skeletal tissue the receptor expressed in the adrenals is 
PTH1R (30). The identification in the sea bream interrenal 
tissue of two receptors, a mammalian PTH1R analog and 
PTH3R, which has so far only been described in fish, raises 
questions about the relative importance of these receptors in 
the responsiveness of the head kidney to PTHrP. Further 
studies will be required to elucidate the role of these two 
receptors in the regulation of cortisol production in fish. 
In vitro studies of zebrafish PTH1R and PTH3R expressed 
in COS-7 cells reveal that zebrafish PTH1R was similarly 
activated by human PTH, human PTHRP, and Fugu PTHrP. 
Conversely, zebrafish PTH3R showed higher affinity for hu- 
man PTHrP and Fugu PTHrP (7, 8). 
Until recently, all evidence suggested that PTHRs signal 
principally via the AC-PKA signaling pathway and second- 
arily via the PLC-PKC-intracellular Ca2+ signaling pathway 
(6). The previously mentioned zebrafish COS-7 cells trans- 
fection studies established that zebrafish PTH1R and PTH2R 
grouped with isolated mammalian receptors. However, the 
fish-specific receptor, zebrafish PTH3R, activated the AC- 
PKA signaling pathway but not the PLC-PKC-intracellular 
Ca2+ signaling pathway (8). In the present study, PTHrP- 
stimulated cortisol production from the head kidney was 
only completely blocked when inhibitors to both pathways 
were used, indicating that most likely PTH1R, which signals 
via both pathways (AC-PKA and PLC-PKA), is the receptor 
involved. However, it has not been possible to confirm or 
determine the relative importance of PTH1R and/or PTH3R 
in the PTHrP-stimulated cortisol response, and no informa- 
tion about the functional importance of these receptors in fish 
is available. One observation for which we do not have a 
good explanation is that, although (7–34)PTHrP was able to 
inhibit cortisol and cAMP production, it did not appear to be 
effective in blocking the PLC-PCK pathway. One possibility 
is that partial blockage of each pathway is enough to block 
cortisol production, as indicated by the effect of SQ-22536 
and U-73122 inhibitors, which only block cortisol when both 
are used together. The precise ligand regions of (1–34)PTHrP 
involved in the stimulation of PLC and PKC have not yet 
been clearly identified. However, it has been shown that (1–
31)PTH stimulates AC but not PLC in mouse kidney cells, 
indicating that the C-terminal amino acids of (1–34)PTHrP 
are involved in the activation (31). However, replacing Glu19 
for Arg19 in human (1–28)PTH restored PLC signaling and 
   
 
ligand-binding affinity, and (1–28)PTH is the shortest human 
PTH peptide that could fully activate both AC and PLC. 
Furthermore, PLC activity was reduced by substituting Gly1 
for Ser1 in human (1–34)PTH and was eliminated entirely by 
removing either residue 1 or the a-amino group alone. Thus 
it has been concluded that the N-terminal determinants of 
AC and PLC activation in human PTH(1–34) overlap but are 
not identical (32). Our results with piscine PTHrP peptide are 
consistent with the observations made with PTH in human. 
In summary, the present study clearly shows that (1– 
34)PTHrP behaves as a glucocorticoid secretagogue in inter- 
renal tissue. The stimulatory effect of N-terminal PTHrP is 
not caused by its binding to ACTH receptors but probably 
occurs via activation of PTH1R and PTH3R, both of which are 
expressed by sea bream interrenal tissue. Upon ligand bind- 
ing, both the AC-PKA and PLC-PKC-intracellular Ca2+ sig- 
naling pathways are activated in interrenal tissue, leading 
ultimately to increased cortisol production. The corticoste- 
roidogenic effect of the N-terminal region of PTHrP appears 
to have been conserved during evolution because it is present 
in both fish and mammals, although the physiological rele- 
vance of this effect remains to be established. It appears that 
the paracrine action reported for PTHrP and other members 
of the glucagon family in mammalian adrenals (9) can be 
extended to the homologous interrenal tissue of the sea 
bream and possibly other teleosts. 
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